POPULARITY
Categories
328 episodes with cancer treatment
126 episodes with cancer treatment
44 episodes with cancer treatment
55 episodes with cancer treatment
17 episodes with cancer treatment
45 episodes with cancer treatment
30 episodes with cancer treatment
19 episodes with cancer treatment
38 episodes with cancer treatment
18 episodes with cancer treatment
30 episodes with cancer treatment
13 episodes with cancer treatment
18 episodes with cancer treatment
10 episodes with cancer treatment
12 episodes with cancer treatment
16 episodes with cancer treatment
15 episodes with cancer treatment
11 episodes with cancer treatment
10 episodes with cancer treatment
8 episodes with cancer treatment
21 episodes with cancer treatment
9 episodes with cancer treatment
15 episodes with cancer treatment
6 episodes with cancer treatment
16 episodes with cancer treatment
15 episodes with cancer treatment
26 episodes with cancer treatment
18 episodes with cancer treatment
18 episodes with cancer treatment
18 episodes with cancer treatment
7 episodes with cancer treatment
21 episodes with cancer treatment
17 episodes with cancer treatment
18 episodes with cancer treatment
15 episodes with cancer treatment
15 episodes with cancer treatment
8 episodes with cancer treatment
16 episodes with cancer treatment
16 episodes with cancer treatment
18 episodes with cancer treatment
15 episodes with cancer treatment
7 episodes with cancer treatment
11 episodes with cancer treatment
10 episodes with cancer treatment
18 episodes with cancer treatment
17 episodes with cancer treatment
11 episodes with cancer treatment
8 episodes with cancer treatment
8 episodes with cancer treatment
9 episodes with cancer treatment
7 episodes with cancer treatment
6 episodes with cancer treatment
9 episodes with cancer treatment
10 episodes with cancer treatment
8 episodes with cancer treatment
9 episodes with cancer treatment
8 episodes with cancer treatment
15 episodes with cancer treatment
124 episodes with cancer treatment
3 episodes with cancer treatment
7 episodes with cancer treatment
7 episodes with cancer treatment
10 episodes with cancer treatment
6 episodes with cancer treatment
3 episodes with cancer treatment
4 episodes with cancer treatment
15 episodes with cancer treatment
4 episodes with cancer treatment
5 episodes with cancer treatment
5 episodes with cancer treatment
4 episodes with cancer treatment
7 episodes with cancer treatment
7 episodes with cancer treatment
5 episodes with cancer treatment
10 episodes with cancer treatment
6 episodes with cancer treatment
6 episodes with cancer treatment
6 episodes with cancer treatment
4 episodes with cancer treatment
9 episodes with cancer treatment
3 episodes with cancer treatment
5 episodes with cancer treatment
2 episodes with cancer treatment
9 episodes with cancer treatment
7 episodes with cancer treatment
6 episodes with cancer treatment
16 episodes with cancer treatment
5 episodes with cancer treatment
5 episodes with cancer treatment
4 episodes with cancer treatment
3 episodes with cancer treatment
11 episodes with cancer treatment
5 episodes with cancer treatment
6 episodes with cancer treatment
6 episodes with cancer treatment
4 episodes with cancer treatment
4 episodes with cancer treatment
5 episodes with cancer treatment
4 episodes with cancer treatment
4 episodes with cancer treatment
9 episodes with cancer treatment
4 episodes with cancer treatment
5 episodes with cancer treatment
5 episodes with cancer treatment
6 episodes with cancer treatment
4 episodes with cancer treatment
2 episodes with cancer treatment
4 episodes with cancer treatment
4 episodes with cancer treatment
5 episodes with cancer treatment
4 episodes with cancer treatment
4 episodes with cancer treatment
4 episodes with cancer treatment
7 episodes with cancer treatment
9 episodes with cancer treatment
3 episodes with cancer treatment
3 episodes with cancer treatment
4 episodes with cancer treatment
3 episodes with cancer treatment
4 episodes with cancer treatment
5 episodes with cancer treatment
5 episodes with cancer treatment
5 episodes with cancer treatment
3 episodes with cancer treatment
12 episodes with cancer treatment
2 episodes with cancer treatment
2 episodes with cancer treatment
6 episodes with cancer treatment
5 episodes with cancer treatment
2 episodes with cancer treatment
3 episodes with cancer treatment
2 episodes with cancer treatment
4 episodes with cancer treatment
3 episodes with cancer treatment
3 episodes with cancer treatment
3 episodes with cancer treatment
2 episodes with cancer treatment
2 episodes with cancer treatment
2 episodes with cancer treatment
3 episodes with cancer treatment
3 episodes with cancer treatment
4 episodes with cancer treatment
11 episodes with cancer treatment
3 episodes with cancer treatment
2 episodes with cancer treatment
13 episodes with cancer treatment
2 episodes with cancer treatment
2 episodes with cancer treatment
3 episodes with cancer treatment
2 episodes with cancer treatment
7 episodes with cancer treatment
3 episodes with cancer treatment
3 episodes with cancer treatment
Scientists in Australia are using CRISPR technology, which allows them to edit out specific genes to open up the treatment options for people with blood cancer. Professor Marco Herold and his team at the Olivia Newton-John Cancer Research Institute have been focused on helping patients who're resistant to lymphoma drugs, and now, they think they've achieved something that could help alleviate the lives of millions of people.
Limiting the side effects of cancer treatments has been an animating force in the field of oncology for many years, and there's been progress to report on that front, but what if you could target cancer tumors without using radiation or chemotherapy and instead generate heat from inside the tumor to kill cells? That's the quest of our guest today, Dr. Hadiyah-Nicole Green, whose promising research using lasers and nanoparticles to eliminate tumors received Breakthrough Device Designation from the FDA earlier this year. “The laser beam that we're using is low power like a laser pointer, and without activation by the laser, the nanoparticles are harmless. Both are targeted just at the site of the tumor so because we don't use systemic delivery, we avoid all of the systemic side effects,” she explains.Dr. Green is also the founder and president of the Ora Lee Smith Cancer Research Foundation, named for an aunt who raised her and who died of cancer without pursuing curative treatment because of her fear of the side effects. Shortly after, her aunt's husband also died of cancer, opting for treatments that took a heavy toll on his body. “At 22 years old, I saw the horrors of cancer and the horrors of cancer treatment and just felt in my heart that there has to be something better than this,” she tells host Michael Carrese.On this fascinating episode of Raise the Line from Elsevier, we'll explore the science behind Dr. Green's approach, the challenges of raising the millions of dollars needed for human clinical trials, and rethinking the current funding landscape for cancer treatments.Mentioned in this episode:Ora Lee Smith Cancer Research Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
Send us Fan MailThe September changes to Australia's PBS will have a wide and lasting impact on the oncology treatment landscape.Rachael Babin from the Oncology Network sits down with Professor Craig Underhill to translate the latest Australian Pharmaceutical Benefits Scheme (PBS) oncology and haematology listings into what clinicians actually need: who's eligible, what the key trials show and what to watch for once the script is written. This month we unpack three significant PBS developments:We discuss the new multi-cancer listing for pembrolizumab, expanding access for patients with advanced or metastatic immunotherapy-sensitive cancersThe listing of enfortumab vedotin in combination with pembrolizumab for previously untreated advanced urothelial cancerAnd the addition of durvalumab alongside FLOT chemotherapy as neoadjuvant and adjuvant treatment for resectable gastric and gastroesophageal junction cancers. We discuss the clinical evidence behind these changes, some of the practical considerations around managing treatment-related toxicities and new funding to expand specialist prostate cancer nursing services.If this helped you keep up with PBS oncology and haematology updates, please subscribe, share it with a colleague and leave a review so more clinicians can find us.Visit the Show Notes for links to the papers and other materials related to the PBS updates discussed in this episode and to send us audio feedback or questions for future episodes.Proudly produced by The Oncology Network - with thanks to our Editor, Graham Knowles.
There's a phrase that shapes cancer treatment more than most of us realise: “the average patient”. It's who a treatment plan is actually built for - not for the patient specifically, but a statistical composite drawn from clinical trials. And once a patient starts on the recommended drug, it is often eight to twelve weeks before a scan tells you whether it was ever going to work for your tumour, specifically. And the odds aren't great to begin with - roughly 19 out of 20 cancer drugs that enter human trials never make it to approval. Today we're talking to Dr Christoph Meinert, co-founder & CEO of Brisbane-based Gelomics, who’s trying to close that gap. How? He’s using AI to build a digital stand-in for an individual patient's own tumour, so doctors can test treatments on it before they ever test them on the human. Learn moreThis episode is sponsored by Google, but they have had no editorial influence over the content we are sharing in today’s podcast. Host: Sam KoslowskiGuest: Dr Christoph Meinert, Gelomics co-founder & CEOProducer: Orla Maher Want to support The Daily Aus? That's so kind! The best way to do that is to click ‘follow’ on Spotify or Apple and to leave us a five-star review. We would be so grateful. The Daily Aus is a media company focused on delivering accessible and digestible news to young people. We are completely independent. Want more from TDA?Subscribe to The Daily Aus newsletterSubscribe to The Daily Aus’ YouTube Channel Have feedback for us?We’re always looking for new ways to improve what we do. If you’ve got feedback, we’re all ears. Tell us here. Shot on Fujifilm.See omnystudio.com/listener for privacy information.
This interview is disseminated on behalf of Theralase Technologies Inc.Theralase Technologies Inc. (TSXV: TLT | OTCQB: TLTFF) Chairman, President, and CEO Roger Dumoulin-White, B.Sc, P. Eng. discusses the company's clinical-stage cancer treatment technology and its development for patients with BCG-unresponsive non-muscle invasive bladder cancer. The interview covers interim Phase II clinical study results for Ruvidar®, including response durability and safety, as well as the potential advantages of Theralase's drug and proprietary light activation system.Learn more: https://theralase.com/Watch the full YouTube interview here: https://www.youtube.com/watch?v=sb-_w3PoR_kAnd follow us to stay updated: https://www.youtube.com/@stockstowatchofficial
A new mRNA vaccine for melanoma is making headlines. Moderna and Merck recently announced results from their clinical trial suggesting that this new vaccine, in combination with the cancer drug Keytruda, reduced recurrence rates in patients. The companies have not yet released full data from the trial. So, how does the vaccine work? And does this mark the beginning of a new era of cancer treatments using mRNA vaccine technology? Ira talks with physician Michael Postow, whose patients were part of the drug trial at Memorial Sloan Kettering Cancer Center. Guest: Dr. Michael Postow is chief of the melanoma service at Memorial Sloan Kettering Cancer Center. Transcript will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
This week on The PQI Podcast, we are joined by Pat Garcia-Gonzalez, Co-founder and CEO of The Max Foundation. Founded in 1997 in honor of Pat's stepson, Maximiliano “Max” Rivarola, The Max Foundation has grown into a global organization focused on accelerating health equity and helping patients access cancer treatment and care. Today, the foundation works in more than 80 low- and middle-income countries and channels more than 10 million doses of cancer medications to patients each year. Pat joins us to share Max's story, how the foundation has evolved over nearly three decades, and the challenges patients around the world continue to face in accessing diagnostics, medications, and cancer care. We also discuss the importance of global partnerships, patient advocacy, and creating sustainable pathways to treatment. Learn more about The Max Foundation.
In this eye-opening episode of Bladder Cancer Matters, brought to you by the Bladder Cancer Advocacy Network, host Rick Bangs sits down with Todd Davey of Ferring Pharmaceuticals to pull back the curtain on something most patients never hear about: market access. What actually happens between a breakthrough therapy and the moment a patient can affordably receive it? Todd walks listeners through the strategy, value demonstration, and launch planning that determine whether innovative bladder cancer treatments—like ADSTILADRIN®—are covered by insurance and accessible without crushing out-of-pocket costs. It's a candid, behind-the-scenes look at how science, economics, and patient advocacy intersect—and why getting this right can mean fewer barriers, less financial stress, and more options for families facing bladder cancer. If you've ever wondered how new treatments move from the lab to real life, this episode will give you clarity—and a new appreciation for the complex work that helps turn innovation into access.
Send Zorba a message!Zorba's thoughts on the groundbreaking mRNA therapeutic vaccine to combat melanoma.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!
Send Zorba a message!Zorba's thoughts on the groundbreaking mRNA therapeutic vaccine to combat melanoma.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!
The Food and Drug Administration approved a new medication to treat pancreatic cancer. In trials, it extended the survival rate of patients by a median of 13.2 months. Dr. Brian Wolpin from the Dana Farber Cancer Institute explains how the drug works and what it could mean for the future of cancer treatment.Then, a recent study found that at least a quarter of former NFL players who died had chronic traumatic encephalopathy, or CTE. Chris Nowinski, CEO of the Concussion Legacy Foundation shares more about the findings and how they could impact the upcoming football season.And, in Nepal, first responders are searching for survivors after a massive flash flood killed at least 300 people. Suraj Sigdel, Nepal Country Director for Mercy Corps, describes the work he and others are doing on the ground.See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy
PJ talks to David Cullinane who came across some bad news in replies to a recent Dáil question Hosted on Acast. See acast.com/privacy for more information.
P.M. Edition for Aug. 26. Tech reporter Meghan Bobrowsky tells us why the Meta settlement could change how teenagers use some of the world's most popular apps. Plus, the FDA approves a milestone therapy for pancreatic cancer. WSJ reporter Xavier Martinez discusses how the nearly $40,000-a-month drug from Revolution Medicines could change patient outcomes of one the deadliest cancers. And the FBI shuts down a sprawling hacking network linked to China that targeted NASA, the Federal Reserve and critical infrastructure. Sabrina Siddiqui hosts. Sign up for the WSJ's free What's News newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
A personalised mRNA vaccine has shown promising early results in preventing high-risk melanoma from returning when combined with the immunotherapy drug Keytruda. Dr Heidi Hart explains how the treatment works, why the trial results are significant, and what still needs to happen before personalised cancer vaccines could become widely available. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.
In this episode I discuss with Kayla Switlishoff, Nurse Practitioner from the radiation oncology team at BC Cancer Kelowna:The benefits of having pelvic health and quality-of-life conversations before cancer treatment beginsHow pelvic cancer treatments can affect bladder and bowel functionPotential changes to sexual health, including pain, vaginal changes, fertilityTreatment-induced menopause and the physical and sexual health changes that can come with itExercise and movement before, during and after cancer treatmentThe role of pelvic health physiotherapy and cancer rehabilitationWhy some side effects may appear during treatment or months to years laterWhat patients can do before treatment to prepare and advocate for their future healthGynecological Life and Ongoing Wellness GLOW) clinic currently being delivered at the BC Cancer Kelowna center to address survivorship concerns with gynecological cancer patients. Kayla Switlishoff is a Family Nurse Practitioner currently practicing within the radiation oncology team at BC Cancer Kelowna. She attended Mount Royal University and graduated with her Bachelor of Nursing degree in 2013. She then attended the University of British Columbia and obtained her Master of Nursing – Nurse Practitioner degree in 2021. She started her NP career providing care to underserved populations at Outreach Urban Health as well as working as a NP hospitalist in Vernon Jubilee Hospital. She then followed her passion of women's health and oncology while completing additional training to start at BC Cancer Kelowna in 2023 and currently works with the gynecological and genitourinary tumour groups. She recently obtained her Menopause Society Certified Prescriber designation and has been one of the co-developers along with Dr. Hamid Raziee of the Gynecological Life and Ongoing Wellness GLOW) clinic currently being delivered at the BC Cancer Kelowna center to address survivorship concerns with gynecological cancer patients. It has been a dream of hers to have a clinic which could address sensitive topics that cancer patients experience in their recovery phase after experiencing similar circumstances with her own health. In her free time, she loves being a mother to her 20-month-old son, baking sourdough, keeping active and spending time with family and friends. For inquires contact BC Cancer (Kelowna): 250-712-3900Please speak with your oncologist for referral to GLOW Support the show
In this episode of Oncology On the Go, CancerNetwork® spoke with Frank McCormick, PhD, about the arc of KRAS-targeted drug development over his 40-year career. He explained why KRAS was long considered “undruggable.” He walked through the origins of the National Cancer Institute's RAS Initiative, which he helped lead starting in 2013, and how that effort produced several of the drugs now advancing through clinical trials for pancreatic cancer.A central moment of the conversation centers on the phase 3 RASolute-302 trial (NCT06625320) data, which showed that daraxonrasib nearly doubled overall survival compared with standard of care in pancreatic cancer. McCormick described this as a turning point that transformed pancreatic cancer from a historically difficult indication into one now seeing a wave of new drug development.McCormick also discussed his vision for cancer prevention. He described a roughly 20-year window between initiating KRAS mutations and clinical disease, and outlined a future in which a safe, well-tolerated KRAS inhibitor could be taken periodically to eliminate precancerous lesions before they progress, potentially preventing KRAS-driven cancers from developing at all.Additionally, he addressed practical considerations for treating clinicians: the feasibility of moving RAS inhibitors into earlier lines of therapy, and the biology oncologists, pharmacists, and genetic counselors should understand about differing KRAS allele subtypes.McCormick is a professor in the Helen Diller Family Comprehensive Cancer Center and holds the David A. Wood Distinguished Professorship of Tumor Biology and Cancer Research at the University of California, San Francisco (UCSF). He has researched KRAS for 40 years and helped lead the NCI RAS Initiative. He was recently named the inaugural recipient of the Stephenson Global Prize from the Stephenson Global Pancreatic Cancer Research Institute.ReferenceDaraxonrasib demonstrates unprecedented overall survival benefit in pivotal phase 3 RASolute 302 clinical trial in patients with metastatic pancreatic cancer. News release. Revolution Medicines Inc. April 13, 2026. Accessed August 19, 2026. https://tinyurl.com/44t5vh5d
Survivor: Africa winner Ethan Zohn joins Rev. Dr. Robin Swan for a powerful conversation about cancer, cannabis, resilience and finding purpose after a life-changing diagnosis. Ethan's life had already taken him from professional soccer to winning CBS's Survivor: Africa when, at age 35, he was diagnosed with a rare form of Hodgkin lymphoma. What followed was an intense medical journey involving chemotherapy, radiation, clinical trials and two stem cell transplants. In this episode, Ethan shares his personal experience with medical cannabis and how it became part of the way he managed some of the physical and emotional challenges surrounding cancer treatment and recovery, including nausea, pain, sleep difficulties and anxiety. Ethan and Robin also discuss the changing conversation around cannabis in professional sports, the importance of responsible education and advocacy, and why patients need honest information when making decisions about their health. The conversation goes far beyond cancer. Ethan explains how surviving a life-threatening illness reshaped his sense of purpose and strengthened his commitment to helping others. He discusses Grassroot Soccer, the nonprofit organization he co-founded that uses the power of soccer to improve the health and lives of young people around the world, as well as Kicking Back, his High Times series exploring the intersection of soccer, cannabis and community. In this episode: Ethan's journey from professional soccer to winning Survivor: Africa Being diagnosed with Hodgkin lymphoma at age 35 Chemotherapy, radiation, clinical trials and two stem cell transplants Ethan's personal experience using cannabis during cancer treatment and recovery Cannabis for nausea, pain, sleep and anxiety The emotional and psychological challenges of cancer survivorship How attitudes toward cannabis are changing in professional sports Cannabis education, responsible use and patient advocacy Turning personal crisis into purpose The story and mission behind Grassroot Soccer Ethan's Kicking Back series with High Times Soccer, cannabis and community Using lived experience to help others facing serious illness Learn more about Ethan Zohn Ethan Zohn:https://ethanzohn.com Grassroot Soccer:https://grassrootsoccer.org Cannabis Health Radio Visit:https://cannabishealthradio.com If this conversation could help someone you know, please share the episode. Subscribe to Cannabis Health Radio for more conversations with patients, advocates, researchers and others exploring cannabis, health and healing. Connect with Cannabis Health RadioVisit us at CannabisHealthRadio.comExplore products and resources from Swan ApothecaryFollow Cannabis Health Radio on Facebook and InstagramImportant DisclaimerThe views and opinions expressed by guests on Cannabis Health Radio (CHR) are their own and do not necessarily reflect those of CHR, its hosts, producers, affiliates, or sponsors. CHR is not responsible for statements or opinions expressed by its guests.Nothing presented in this episode constitutes medical advice, diagnosis, treatment, or a recommendation regarding what you should do. This content is provided for informational and entertainment purposes only. Always consult a qualified healthcare professional regarding your health, medical conditions, medications, or treatment decisions. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Recorded live at the Healing Pen & A Mic journaling workshop in St. Paul, this episode brings you straight into the room.Nancy stepped out of a afternoon of writing alongside fellow cancer patients and survivors to sit down with host Talaya Dendy. Diagnosed with acute promyelocytic leukemia in 2018, Nancy speaks with quiet honesty about the specific kind of isolation that can follow you even in a crowded room. She shares what happened when treatment ended and the appointments stopped, how her perspective on healing transformed, and what keeps her grounded when disconnection creeps back in.If you have ever felt isolated after a diagnosis or wondered what comes next when treatment stops, this conversation offers a space to process those feelings alongside people who understand.✨ Episode Highlights:01:32 Nancy shares her 2018 leukemia diagnosis and its sudden onset01:45 What it feels like to write in a room surrounded by people who understand: "a freeing sensation and just a validation"02:37 The reality of feeling alone even when supported by medical staff and family03:33 Redefining healing as an ongoing practice rather than a quick fix04:03 Practical advice for navigating isolation after a diagnosis04:33 The abrupt transition after chemo ends and the quiet that followsAbout the Guest: Nancy Tepley-Mimbach was diagnosed with acute promyelocytic leukemia in 2018. She joined the Healing Pen & A Mic workshop seeking the community connection that felt missing after her active treatment ended.Take the Next StepAttend a Workshop (Twin Cities): Join us for the next Healing Pen & A Mic journaling workshop on Saturday, October 4th. Save your spot: https://bit.ly/healingpenwaitlist
Ofer Shalev, co-founder and CEO of New Phase, shares his journey from leadership roles across high-tech, biotech, banking, and even serving as a fighter pilot, to pioneering a nanotechnology-based hyperthermia treatment aimed at transforming stage four cancer care. Ofer explains how the company's mission focuses on prolonging life while preserving quality of life through a systemic approach designed for metastatic disease. He discusses New Phase's progress, including treating 33 stage four patients (including at Mayo Clinic), achieving stable disease in over 60% of cases after one month follow-up, securing FDA medical device designation and IDE approval, and building a science-driven team supported by patents and peer-reviewed publications. Guest links: https://newphase.co.il/ Charity supported: Feeding America Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com. PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical EPISODE TRANSCRIPT Episode 087 - Ofer Shalev [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I'm delighted to welcome as my guest, Ofer Shalev. Ofer is the co-founder and CEO of New Phase. With more than twenty-five years of management experience in the high-tech and biotech industries, Ofer leads New Phase operations and is pioneering a breakthrough nanotechnology-based treatment to transform the management of stage four cancer. Ofer combines deep technological insight with strategic business acumen. He previously served as CEO of several technology companies, including ReDent Nova, which led innovation in dental medical devices alongside his co-founder, Dr. Rafael Hof. Earlier in his career, he held senior leadership roles in the banking sector, including serving as VP of Operations, which strengthened his foundation in large-scale operational excellence. He holds an MBA from the University of Edinburgh and is recognized for guiding multidisciplinary teams, driving complex R&D initiatives, and scaling companies from concept to global market presence. At the core of his work is a clear mission: to redefine the future of cancer care by offering patients a safer, more targeted, and more effective treatment, one that not only attacks tumors but also preserves the quality of life. All right. Well, welcome to the show. I am so thankful you're here today. [00:02:09] Ofer Shalev: Thank you, Lindsey. Good evening. Very nice to meet you. [00:02:11] Lindsey Dinneen: Very nice to meet you too. So I would love, if you wouldn't mind starting off by just sharing a little bit about yourself, your background, and what led you to medtech? [00:02:25] Ofer Shalev: Well, I would say that during the year, I had extensive managerial experience across many multiple sector, including industry, high-tech, banking, and obvious-obviously life science. I have also to mention that about fifty years ago, in my experience I was a fighter pilot, pilot in the Israeli Air Force. It was, again, about fifty years ago. I would say that it probably significantly shape who am I today. I mean, it's developed my ability to to take a calculated risk, for example, or to act quickly and precisely to plan ahead, to build contingency plans. So all that kind of thing that probably was very relevant to the time I, I w- I used to serve in the Israeli Air Force, but also very relevant to the, to the industry. Okay? And furthermore, I would like to say that probably I am highly motivated by challenge. It, it's make my day. In addition, I am a father to four children and a grandfather of seven grandchildren. And I do hope that at the end, I will have about twelve grandchildren. So, the kids have still to work about it. Yeah. And I would say that you asked about myself, so probably I have a very, very strong belief in the path, in the way that I'm choosing. It's I would say, enabl-enabling to, to overcome about the difficulties, mainly when you're looking for challenge, especially in, in a new and unfamiliar field, like in our case of New Phase And furthermore, I, I, I, I truly believe in the word "never give up." You will find solution to everything. Never give up. I like very much as I mentioned before, to, to meet a challenge and to overcome our challenge many times by breaking some problem into pieces and then to assemble it again. Furthermore, I would say we, we met many, many problems in our life. I, I think that we have to focus about the solution, not about the problems. You cannot change problems. It's happened. But let's try to find and, and to think about how to find the right solution to it. And I would say that I, I f- I feel very, very, very good to to operate or to, to function in a turbulent area. I mean, I like it very much. I, I know that not, not, not anyone like it, but I feel very good in, in this area. [00:04:59] Lindsey Dinneen: Wonderful. Well, thank you for sharing a bit about your background. I have so many questions, but I would love to actually learn about what you're doing right now with New Phase, because I know you're passionate about it. There's, there's a lot that goes into cancer research and treatment, and I know that that's been such a challenge for so many years, and I love the fact that your company is really diving into that challenge and tackling it. And I was just wondering if you could explain where the concept of New Phase came from, and what exactly makes your company so unique in this space? [00:05:39] Ofer Shalev: So the, the idea came that it was 14, 14, 15 years ago, while me and my partner, Dr. Rafael Hof, we were involved with some other company, and after that at that time his mother, her name was Sarah, she wa- she had lung cancer. She passed away. And during that time, we have a very, I mean, many time conversation about the disease. No, no, no, none one, none one of us is, was oncologist, okay, by training. But we have many, many discussion about the treatment what are the relevant treatment that are available, et cetera, et cetera. And after she passed away we, I mean, Rafi, who is a great technology guy, came with this idea of nanoparticles and hyperthermia, and we start to work about it. Again, we have to learn, both of us, we have to learn a new area of technology, of biology, of chemistry, of physics, engineering, regulation, everything. And it was not only that we have read and learn about it, but we decide al-also to, let's say, to, to jump into the pool, into the water. We put each one of them, each one of us put some money. We hire some chemist. We also hire from one of the university in Israel some space. Like you, I mean, usually, I, I believe it's the right way to develop a company. I mean, to start and building it, the company, in the garage, okay? Right. And, and, and sure, you have, you have to-- you cannot just think about it, you have to, to, to do something. And the outcome was actually the proof of concept. We show in the in vitro, under microscope, how some very, very primitive nanoparticles were being irradiate, caused damage to the cancer cells. And that was the time that we founded New Phase. I truly believe that it's the right approach that first you have by yourself to, to deliver, to show the proof of concept, then go to investor and try to convince them to, to invest in your in your company. So that was what we have done. It was a very, very long way. I mean, the company was founded just 13 years ago. The vision didn't change. I mean, from the beginning, the idea was to prolong life of cancer patient, and in order-- and in addition to maintain the quality of life. At that time we used the word of chronic treatment or managing the disease, and many of the people that we met, skeptical one said, "But you, you don't cure the disease." So we explained that as we see in the next twenty years, nobody will cure the disease, but for the meantime, people have to live. [00:08:35] Lindsey Dinneen: Hmm. [00:08:36] Ofer Shalev: Now, the vision is still today. It was implemented into a technology. But yes, the technology was changed several time along the year, but the vision is still here, and that is, that is the, the outcome as of today. We already treated thirty-three patient with stage four, six of them in a Mayo Clinic, very distinguished hospital. I mean, I would say ranked number one worldwide. A great cooperation with them. I would say that till the summertime, we will treat another six patient, and after we move to the feasibility study, where we will have to choose few indication, and we will add another to a US hospital to join to the feasibility study. It become a product. As I mentioned, we treated already thirty-three patient. We have about fourteen patents that already granted. We have about, since we are-- we truly believe that we are in a deep science company, so we truly believe in the, in the scientifics based evidence, and we already publish nine peer review scientific articles. We have done a lot of work and success with FDA. First, and again, it was a breakthrough idea to, to succeed and get designation of medical device. Although we inject infused nanoparticle into the body, but we convinced the FDA that although we infuse nanoparticle, hence our mode of action, primary mode of action is actually engineering one or physical one, and therefore we were, we were designated as a medical device, which again save a lot of budget and, and time while reaching to the clinical study. And then later on, we got the IDE, I mean, the, the approval to start clinical study in the US. So we have done a very, very long way, and I would say that it's very satisfying while seeing today that first of all, we have a product, not only idea, and the vision is still here. I mean, what we can see that we... many of the patient, although it in the early feasibility study, and the main goal is to achieve safety and to show it's non-toxic. So even though we succeeded in more than about sixty percent of the cases we treated in nine different indication of cancer to reach to a stable disease. Let's say after one month of follow-up, the tumor metastasis are the same size, and there were no new lesion during that time. So, yeah, we-- I would say that it start, it start-- it seems that we start to reach to the, to the real game in the feasibility study where we will focus about two to three indication, and the idea is to treat patient for at least, let's say, six months, and to show that we can, we can keep them in a status of stable disease. [00:11:44] Lindsey Dinneen: Yeah. [00:11:45] Ofer Shalev: Further, furthermore, all the patients that we got, all of them are metastatic stage, let's say stage four, which exhausted all other treatment. So many time, you can see that in the retrospective data, before the joining to the study, the tumors or metastases have a progression rate of so and so percent per month, and after our treatment is dramatically reduced or even stopped. So, a lot of enthusiasm with the current status. [00:12:18] Lindsey Dinneen: Yeah, a lot of enthusiasm and a lot of hope. I, I love what you're doing because, yeah, as you said, I mean, at that point, people probably feel so stuck and hopeless. And so to be able to learn that there is technology that is being actively worked on that can... [00:12:36] Ofer Shalev: Yeah. [00:12:36] Lindsey Dinneen: ...really help them [00:12:38] Ofer Shalev: Yeah, yeah. We are-- you also ask what, what we-- what, what is the difference that we bring to the market? [00:12:42] Lindsey Dinneen: Mm-hmm. [00:12:44] Ofer Shalev: So the hyperthermia is well-known for many, many years to be a useful way to treat cancer. Okay? Because cancer don't have resistance to hyperthermia. And let's skip about all the biology factor, but this is a well, well-written evidence in, in the literature. So, but usually all the current hyperthermia methodology is a local treatment, meaning you have to define where the tumor is, CT, MRI, whatever, and to try, try to heat this tumor either by infrared or with-- or inject directly nanoparticles into the tumor, et cetera, et cetera. What we are offering is a totally a new approach of treating systemically in tumors at stage four. Let's say in many cases, you don't know even where the tumors are in the volume of treatment, meaning we treat the torso area. It's not that we are trying to find tumor by tumor. No. We're treating the whole area of the torso, and by that we can destroy the tumor, which in stage four are localized in, in different area in it. So this is one thing. The other thing that I would say that the stage four mainly people that exhausted other treatment is really can be considered as a unmet need. And that's, that's the population that we are focused about. That, that's the population that we are focused about. [00:14:11] Lindsey Dinneen: Yeah. Yeah, that is really incredible to hear. I, I love what you're doing. I'm curious, as you've gone about this process and f- you know, 13 years worth of learnings and growing as a company, what is something that's really surprised you along the way? [00:14:34] Ofer Shalev: Surprise? Well, you know, I said before, when, when you, when you start this this journey with a deep s-- belief in yourself and in your team, you're not really surprised. [00:14:49] Lindsey Dinneen: Hmm. [00:14:50] Ofer Shalev: Yeah, I mean, no, there is a lot of surprise. I mean, we, we went in an area which nobody stepped before in the, in those days. Nobody stepped before. But I would say it was obvious to me at least that okay, we are thinking about the right approach. We are trying to find our way. We invest a lot about trying to read whatever is relevant. We are speaking with oncologists, learn from them in many time about the failure, and try to make sure not to do it. So I'm not surprised. I'm very happy. And again, it's not... It was not by accident. On one hand, a very strong belief, and on the other hand, in-depth learning every piece of knowledge that we were able to collect [00:15:33] Lindsey Dinneen: Yeah. Yeah, that's so important, and I appreciate you saying it that way. I think intentionality is such a key component of leadership, and this is some of the conversations that I'm enjoying having lately is, h- and I'd love to get your input, is how do you go about intentionally creating the right team, the right vision, and the right culture to support the fact that you don't have to be surprised by things? You get to be happy, but you have the right framework in place. [00:16:08] Ofer Shalev: So I would say that in terms of the team, it was changed and replaced along the way. [00:16:15] Lindsey Dinneen: Mm-hmm. [00:16:17] Ofer Shalev: At the beginning... By the way, even today we have we have, we have twenty-four employees. Six of them are PhD Along the way, since we need people that know how to read articles, how to analyze article, et cetera. So I would say that we have in a, in a, in a company of about six, seven employees, three or four of them were PhD. There was a lot of self-learning to do. Later on, we start to make, "Okay, we have to develop. We have to build a product." So obviously, we, we, we mixed this team with people that came f- with some experience from the industry. Furthermore, experience from the medical device industry. Okay? So I would say along the time the, the, the population in New Phase become to be more heterogeneous. [00:17:08] Lindsey Dinneen: Hmm. Mm-hmm. [00:17:10] Ofer Shalev: Because really we-- you-- I mean, currently we have a product, so we need people about regulation, about quality, people that know very well engineering, people that have a idea about operation and not only researcher. But again, at, at the beginning, all, all our employee came from the... I mean, we, we, we, we re recruit about I think three or four PhD at the beginning to start with, and it will change along the way. Yeah. Now about-- you ask about leadership. So, I would say that I ca- I can see the leadership not only about, about leading people, but also about pushing your vision. Okay? Because again at the beginning, an idea of changing the cancer disease into a manageable disease, it was not so well accepted idea. Anyone ask about curing, but we keep saying, "No, there is no, there's no g- currently, there's not a real good chance of curing. Let's focus about prolonging life." Nowadays, it's common language. You can see from any, any drug company discuss the issue of manage- manageable disease. But when we start with this vision, it was very hard to convince people about it, and obviously many of them said in a very skeptical way, "You will not make it." [00:18:29] Lindsey Dinneen: Mm. [00:18:29] Ofer Shalev: So this part of the leadership as well, "Okay, I heard you. Let's, let's meet at the end of the day and we'll see what hap- who, who is the right one." So, yeah. So I would say that in our case, leadership is, is mainly to, to maintain the vision, to push the vision, to develop the vision. Partially it's about, a- about employees, sure, because at the end you have to recruit employees that will implement this vision into a technology, into a product But I would say that in a company like New Phase, the, the leadership is as more than 50% is about the vision. [00:19:11] Lindsey Dinneen: Yeah. Yeah, pushing the vision forward. I, I really appreciate that. I, you know, you had so many things at the beginning that you were talking about that I really appreciated. You talked about never giving up, overcoming difficulties, and loving challenges, and I think all of those are critical, of course, as an entrepreneur. But I'm also particularly curious about your h- you mentioned that you break down challenges into pieces and then rebuild, and I'm curious, where did that philosophy come from and how do you practically implement it? [00:19:48] Ofer Shalev: Frankly speaking, I don't know from where it came. No, I don't know. I mean, you know, with... Du-during the way, I, I, I had many, many chance to, to, to rethinking about some problem that we solved, and I asked myself, "How the hell we know what to do?" I, I don't know, frank- In, in many times, I would say that main-ma-mainly because we try to simplify the problem to pieces, and then we have a breakthrough id-idea about it. It is not-- I mean, the methodology is about breaking the problem into pieces. How to assemble it again, this is a breakthrough. I don't know how to explain it. [00:20:32] Lindsey Dinneen: Okay. [00:20:33] Ofer Shalev: really. [00:20:33] Lindsey Dinneen: Yeah, but do you find that maybe taking it apart and so probab- maybe part of it is, I wonder, you know, when you've got a challenge, it feels big and insurmountable, and you can't make any progress versus if you break it down and you go, "Okay, yeah, maybe this as a whole feels t- like too much, but what about this one little piece that if I can overcome this, then it will push me forward in overcoming the ultimate challenge?" I wonder if it's partly... [00:21:02] Ofer Shalev: It, it, it might be, it might be the situation. It's simple to, to deal with a, with a simple or with a, with a partial challenge, partial partial problems. And then it says, "Okay, I, I, I solved this issue. Let's try to solve another issue." And all of a sudden, you figure out that, "Hey, I have the full picture. I solve it." [00:21:23] Lindsey Dinneen: Yeah. That's, that's really cool. Okay. So, you know, you've had an amazing career, and not just within this space of course, but before that, and I'm just wondering if maybe especially along this particular journey with New Phase, are there any moments that really stand out to you as affirming, "Wow, I am in the right place at the right time in the right industry"? [00:21:54] Ofer Shalev: Yes. I, I, you know, I, I think that it's... No, it will, it will par-- it will par-- I, I will answer you partially. I mean, once we decided to founder the company and that myself and my partner, Dr. Rafael Hof, we have after another company that we, we had, and we-- And when he came with this idea, I thought to myself, "If there are two entrepreneur worldwide that are able to deal with that problem, it's probably the two of us." Yeah. Ab-absolutely. Yeah. [00:22:31] Lindsey Dinneen: Yeah. [00:22:32] Ofer Shalev: Because the way that we work together, the w- the way that we each one of each one of us cover different area, how to build this kind of a crazy idea. I would say that really just only, you know, two people that are crazy enough and can work so well together can deal and succeed in this task. So this is the kind of, of, of of memory that I have from the beginning of the company. [00:22:57] Lindsey Dinneen: Yeah. I love that. That's, that's really cool. You, you know, you mentioned also at the beginning that some of your experience as a pilot was really critical in helping you learn different skills or disciplines that help you succeed throughout your career and today. Do you mind just talking a little bit more about some of the things that you still hold onto as really important lessons learned? [00:23:24] Ofer Shalev: Okay, know, to be in a, in a cockpit of a fighter i-- of a, of a fighter airplane, I mean, just ones that was there can, can understand what I'm speaking about. But it's a who- the whole way of thinking. So I would say that from time to time, when I have quite, quite a big challenge, I, I, I imagine to myself that I'm in the cockpit, okay? In order to, to think the same way that you used to think fifty years ago. Okay? Now with, wi-with, with regarding with regarding it to to some advice, okay? To to some to some other entrepreneur, let's call it this way. So, I would say that first of all, choose a real breakthrough idea. Not an idea that, okay that probably someone else did before or will do it after-- will, will make it after you. Try to find a real breakthrough idea to... Because, you know, at the end, you, you sacrifice a, a big piece of your life about it. [00:24:24] Lindsey Dinneen: Mm-hmm. [00:24:25] Ofer Shalev: So try to find something which is real, real something. This is one. Then you have to have a very strong backbone and remain committed to your vision. Yes, you might change the technology, that's okay, but you have to be committed to your vision. And furthermore, probably many times along the way, you will hear from people you will not succeed, it's the wrong way, et cetera, et cetera, et cetera. So nowadays, when I hear this kind of a voice, I say, "Why don't you open the startup of yourself? If you know it so well, why don't you open? Because you don't have the courage?" [00:25:06] Lindsey Dinneen: Mm-hmm. Mm-hmm. [00:25:08] Ofer Shalev: And yes, courage is, is, is, is another component which is very important to entrepreneur that choose a way how to change the world. [00:25:18] Lindsey Dinneen: Mm. Yeah. I love that. Thank you for sharing. Okay, so pivoting the conversation a little bit just for fun, imagine that you were to be offered a million dollars to teach a master class on anything you want. Could be within your industry, doesn't have to be. What would you choose to teach? [00:25:40] Ofer Shalev: I don't know how to do it, but I will say it in other ways. I probably to, to, to, to teach people how to avoid or what to do while you are in a dead end. [00:25:52] Lindsey Dinneen: Hmm. Okay. Do you wanna elaborate a little bit? 'Cause I'm curious. [00:26:00] Ofer Shalev: I think that, that, that your ability really to believe in yourself is a key factor. [00:26:05] Lindsey Dinneen: Mm-hmm. Mm-hmm. [00:26:06] Ofer Shalev: Your ability to, to free your mind, not to focus about the current problem, but to free your mind, going outside and try to find some other idea is quite important one. [00:26:18] Lindsey Dinneen: Yeah. [00:26:18] Ofer Shalev: Yeah, those kinds of things. Probably we have to think about this kind of a masterclass. [00:26:23] Lindsey Dinneen: That would be a great masterclass, yeah. Okay. All right. [00:26:27] Ofer Shalev: By the way, I, I truly believe that in order... I mean, at least that's what I'm doing. But I, I besides that I'm working very hard, I try to read many books. It might be biography, it might be historical novel, it might be by... it might be a thriller. I try to be very, very diverse in what I am reading. I believe it's, it's just fruitful my mind, and not to focus about only about some scientific articles. [00:26:56] Lindsey Dinneen: That's... I love that. That's great. All right. And how do you wish to be remembered after you leave this world? [00:27:06] Ofer Shalev: Well, it's not something that I particularly concerned about it, truly. I don't, I, I don't... I, I, I will say fir- I will say something else. I truly believe that true leader are not focused about what people will remember about them. It is important that the vision will stay. It's important that a father and mother, or children that have cancer in the family will be able to live longer life with a better quality of life. It's much more important if people know, "Hey, Ofer Shalev bring this technology to the market." [00:27:45] Lindsey Dinneen: Mm-hmm. [00:27:46] Ofer Shalev: That, that the way I see it. I mean, I don't care too much what will people remember after I leave this world. [00:27:53] Lindsey Dinneen: Yeah. No, that's, that's beautiful. I love that. Okay, and then final question: What is one thing that makes you smile every time you see or think about it? [00:28:04] Ofer Shalev: Well, that is very, that is very easy. You know, when you have so many, so many grandchildren, so, to hear the questions "Why did, why did it happen?" "Why the bird is flying so high?" The, the truth and simplicity of children and the way that they are thinking, that's really something that make, I think, everybody smiling about it. [00:28:28] Lindsey Dinneen: Yeah. That's so fun, and I couldn't agree more. I I have a few nieces and a nephew, and getting to, to sort of see the world again through their eyes and perspective is just really fun. It's just, it's joyful. [00:28:44] Ofer Shalev: Yeah, it's a great chance to hear about a simple way of, of how the world should, should be. [00:28:49] Lindsey Dinneen: Yeah. Curiosity. I love the never-ending curiosity. [00:28:52] Ofer Shalev: And asking many questions. It's very-- I mean, asking question is, is a great, is a great benefit. [00:28:58] Lindsey Dinneen: Yes. [00:28:58] Ofer Shalev: Ask as many questions as you can. [00:29:00] Lindsey Dinneen: Your whole life. [00:29:01] Ofer Shalev: Yeah. [00:29:02] Lindsey Dinneen: Yeah. Excellent. Well, this has been such a great recording. I really appreciate you sharing your your vision especially about New Phase and where you hope that the company will go and, and the lives that it'll impact. And I know you're well on your way, and I just wanna thank you for not listening to the people who said, "This is not gonna happen," or were trying to discourage you. I'm just so thankful that you're doing what you're doing. And we are honored to be making a donation on your behalf as a thank you for your time today to Feeding America, which works to end hunger in the United States by partnering with food banks, food pantries, and local food programs to bring food to people facing hunger, and they also advocate for policies that create long term solutions to hunger. So thank you for choosing that organization to support. So, really appreciate you being here today and just really appreciate everything you're doing to change lives for a better world. [00:30:00] Ofer Shalev: Thank you very much, Lindsey. [00:30:02] Lindsey Dinneen: All right. You too. Bye. [00:30:04] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.
For the Good of the Public brings you news and weekly conversations at the intersection of faith and civic life. Monday through Thursday, The Morning Five starts your day off with scripture and prayer, as we also catch up on the news together. Throughout the year, we air limited series on Fridays to dive deeper into conversations with civic leaders, thinkers, and public servants reimagining public life for the good of the public. Today's host was Michael Wear. Thanks for listening to The Morning Five! Please subscribe to and rate The Morning Five on your favorite podcast platform. Learn more about the work of the Center for Christianity and Public Life at www.ccpubliclife.org. Today's scripture: Philippians 2:1-11 (ESV) News sources: https://www.christianitytoday.com/2026/08/missionary-kevin-rideout-released-niger-kidnapping/ https://www.wsj.com/health/pharma/moderna-merck-vaccine-succeeds-in-preventing-melanoma-from-returning-540e9e18?mod=hp_lead_pos1 https://www.nytimes.com/2026/08/18/world/canada/tariffs-trade-trump-carney.html https://www.nytimes.com/2026/08/19/us/elections/wyoming-republicans-moderate.html https://www.cnn.com/2026/08/18/politics/takeaways-florida-alaska-primaries https://www.nytimes.com/2026/08/19/us/politics/peltola-sullivan-alaska-senate-primary.html https://www.washingtonpost.com/elections/2026/08/18/california-us-house-special-runoff-election-results-live-wahab-faces-hernandez/ https://www.wyomingpublicmedia.org/politics-government/2026-08-19/freedom-caucus-candidates-come-up-short-in-wyomings-primary Join the conversation and follow us at: Instagram: @michaelwear, @ccpubliclife Twitter: @MichaelRWear, @ccpubliclife and check out @tsfnetwork Music by: King Sis #politics #faith #prayer #scripture #news #missionaries #Christianity #Moderna #medicine #health #Canada #tariffs #trade #elections #Wyoming #Alaska Learn more about your ad choices. Visit megaphone.fm/adchoices
In today's episode, we spoke with Jennifer B. Valerin, MD, PhD. Dr Valerin is an assistant professor in the Divisions of Hematology and Oncology and Medicine at the University of California, Irvine School of Medicine.In our exclusive interview, Dr Valerin discussed the clinical role of liposomal irinotecan (Onivyde) in pancreatic cancer management, factors influencing the decision to use liposomal irinotecan in practice, and developments she is excited to see as the pancreatic cancer landscape is shifting toward highly targeted and combination approaches.
Merck and Moderna have announced that a new mRNA vaccine has succeeded in blocking the return of one of the deadliest cancers. Wall Street Journal reporter Xavier Martinez explains more about the trial and why its giving cancer researchers hope.Then, primaries are underway, and in many races, progressives are prevailing. David Hogg, a progressive Democrat and president of Leaders We Deserve, shares his thoughts on primary results and why he's pushing party leaders to go with younger candidates.And, during the devastating Eaton fire in California, Nikki High turned her bookstore in Pasadena into a hub for mutual aid. High talks about the lessons she learned about community and resistance during that time.See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy
Shares of Moderna and Merck are surging on positive results from a Phase 3 trial of a groundbreaking cancer treatment. After a decade in development, individualized mRNA “vaccines” and established cancer treatment Keytruda result in reduced risk of recurrence or death. Moderna CEO Stephane Bancel and Merck Research Laboratories president Dr. Dean Li discuss this pivotal moment in medicine and how it fits into the long term visions for both Merck and Moderna. CEO of design and coding platform Figma Dylan Field discusses his company's wild year as a public company and building public trust in AI. Plus, it was primary night for Democrats in Florida, investors are scrutinizing revenues from Anthropic and OpenAI, and shares of Unitree are surging in Shanghai, presenting a potential challenge to U.S.-based humanoid robotics. Stephane Bancel & Dr. Dean Li - 15:13 Dylan Field - 33:35 In this episode: Dylan Field, @zoink Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin Katie Kramer, @Kramer_Katie Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Did you know only one type of doctor is legally allowed to treat your cancer, and everyone else is working around a loophole to help you anyway?In this episode of Integrative Cancer Solutions, Dr. K sits down with Robert Carrillo, chief safety officer at CancerDoctor.com, to unpack what most patients never learn about how the cancer care system actually works. Robert explains why oncologists are bound by NCCN guidelines and insurance rules that leave little room for anything outside conventional chemotherapy, radiation, and surgery, and why that leaves patients to build their own care team if they want more options on the table.The conversation covers how to vet an integrative provider, why you need to take personal ownership of your own medical records, and why the "tool bag" available to integrative doctors is more than ten times the size of what conventional oncology alone can offer. If you or someone you love is facing a cancer diagnosis and trying to figure out who to trust and what questions to ask, this episode is a practical roadmap.Key Takeaways:0:00 Introduction1:04 A cancer diagnosis in the family sparks a search for real answers6:00 Doctors work in probabilities and ranges, not certainties14:21 The legal loophole behind who can actually treat your cancer19:10 Why your oncologist cannot discuss options outside standard of care24:48 Cancer is over 100 diseases, and subspecialties matter28:00 The integrative tool bag holds over 20 options conventional care does not31:02 Why the best outcomes come from combining both worlds Schedule a Free 15-Min Cancer/Lyme Consultation at The Karlfeldt Center: 208-338-8902Resources:Cancer Doctor - https://www.cancerdoctor.com/National Comprehensive Cancer Network (NCCN) - https://www.nccn.org/ Medical Disclaimer: This content is for educational purposes only and is not intended to diagnose, treat, cure, or replace professional medical advice. Always consult your physician or qualified healthcare provider regarding any medical condition or treatment decisions.
Moderna shares soar after it announces a positive cancer trial result. AP's Lisa Dwyer reports.
Dina Besic started Maxwell's Toy Box because her two-year-old son Max wanted a train table in his oncology playroom. Three years later, while working a demanding full-time corporate job, raising two kids, and navigating Max's cancer treatment, she built an organization that has supported over 5,000 children, donated $9,100 directly to families, delivered 8,500 toys, and created 4,064 joy packages for children receiving chemotherapy… and she doubled her fundraising year over year with the support of The SPRINT Method™.In this episode, Dina shares how she got out of her own way, moved from begging friends and family to running peer-to-peer campaigns and securing corporate sponsorships, and shifted her donors from giving physical toys to unrestricted cash donations. We also talk about the identity shift that changed everything, and what she would tell the version of herself who was terrified to ask.Topics:How 108 donated toys grew into an organization serving thousands of children and families Moving supporters from donating physical toys to giving dollars the organization can put to work How peer-to-peer fundraising opened the door to corporate sponsorships and new donor acquisitionGetting out of draft mode when you're the founder, fundraiser, marketer, and decision-makerWhat doubling fundraising looks like when you have a full-time job, two kids, and a nonprofit to runFor a full list of links and resources mentioned in this episode, click here.Bloomerang is the complete donor, volunteer, and fundraising management solution that helps thousands of nonprofits like yours. Book your demo here. Read The 2026 Giving Signals Report here. $10K in 10 Days: The Campaign Plan You Can Run From Your Laptop Powered By The SPRINT™ Method - CLICK HERE TO SIGN UP Thursday, August 20th at 12 PM ETResources:Easy Emails For Impact™: The $5K+ Fundraising Campaign SystemPurpose & Profit Club® Fundraising + Marketing Accelerator The SPRINT Method™: Your shortcut to 10K fundraisers Instagram, LinkedIn, website , weekly newsletter [FREE] The Brave Fundraiser's Guide: Stop getting ignored. Start raising more. May contain affiliate links
Kathy talks with Charlotte Bayala, host of The Cancer Caregiver and Caregiver Breathing Room podcasts. Charlotte is also a yoga and meditation teacher and a caregiver for her husband who was diagnosed with cancer over a decade ago. Tune in and learn what inspired Charlotte to start the podcasts, how it has helped her as a caregiver, what she does so she doesn't lose her shit, and why sarcasm and humor are important for caregivers. Listen to The Cancer Caregiver and Caregiver Breathing Room and follow Charlotte on Instagram.Follow Women Who Sarcast podcast on IG @womenwhosarcast and Women Who Podcast magazine @womenwhopodcastmagazine. Get the current issue of Women Who Podcast magazine at womenwhopodcastmag.com.Show music provided by Drrrakhan.All content © 2026 Women Who Sarcast and WWS Productions.
A Clare patient advocate is calling for prostate cancer patients to receive a clearer explanation of the impacts that treatment will have on their health. Research from the Irish Cancer Society has found 66% of patients were either underprepared or completely unprepared for the impact of treatment on their sexual function or mental health. Meanwhile, 80% of respondents stated that a lengthier and clearer discussion with a doctor prior to beginning treatment would have helped them understand more of the potential effects. Chair of HSE MidWest's Patient and Service User Council, John Wall, says the side effects are as difficult to experience as the cancer treatment itself.
Truth Be Told with Booker Scott – Cancer care sparks growing questions about nutrition, metabolic health, natural remedies, and treatment choice as families seek greater transparency. Advocates call for open research into overlooked approaches while emphasizing common sense, honest evidence, and a willingness to examine every option that may improve patient outcomes...
Malpractice Re Cancer Treatment I’m Katelyn Holub, an attorney focusing on personal injury law in northwest Indiana. Welcome to Personal Injury Primer, where we break down the law into simple terms, provide legal tips, and discuss personal injury law topics. Today’s question comes from a caller who said, “My 85-year-old mom died in a nursing […] The post Ep 377 Malpractice Re Cancer Treatment first appeared on Personal Injury Primer.
Beating Cancer Daily with Saranne Rothberg ~ Stage IV Cancer Survivor
In today's episode of Beating Cancer Daily, Saranne introduces a unique and powerful method to navigate cancer treatments easily. Drawing from her own experience of beating Stage IV cancer, Saranne explores the concept of using carefully curated music playlists to transition into and out of treatments. Inspired by an encounter at a Broadway show, she shares insights on creating personalized soundtracks to uplift the spirit, reduce stress, and reclaim a sense of normalcy. Join Saranne as she delves into this creative strategy and offers examples to help you craft your own therapeutic playlists. Get ready to immerse yourself in a blend of music, motivation, and heartfelt advice as we live our best days, beating cancer together daily.2025 People's Choice Podcast Awards Best Health Series FinalistRanked the Top 5 Best Cancer Podcasts by CancerCare News in 2024 & 2025,and #1 Rated Cancer Survivor Podcast by FeedSpot in 2024 to 2025. Beating Cancer Daily is listened to in 148 countries across 7 continents and features over 420+ original daily episodes hosted by Stage IV survivor Saranne Rothberg. To learn more about Host Saranne Rothberg and The ComedyCures Foundation:https://www.comedycures.org/ To write to Saranne or a guest:https://www.comedycures.org/contact-8 To record a message to Saranne or a guest:https://www.speakpipe.com/BCD_Comments_Suggestions To sign up for the free Health Builder Series live on Zoom with Saranne and Jacqui, go to The ComedyCures Foundation's homepage:https://www.comedycures.org/ Please support the creation of more original episodes of Beating Cancer Daily and other free ComedyCures Foundation programs with a tax-deductible contribution:http://bit.ly/ComedyCuresDonate THANK YOU! Please tell a friend whom we may help, and please support us with a beautiful review. Have a blessed day! Saranne
Medical breakthroughs rarely happen overnight. They begin with an idea, grow through years of research, and eventually reach the patients whose lives they may change. Andrea Lopez has spent her career helping make that journey possible. In this week's Celebrate Your Story, Andrea shares how a childhood fascination with medicine led her from Ecuador to New York, where a professor's encouragement opened the door to a career in cancer research. Today, she works at the forefront of CAR T-cell therapy, helping hospitals deliver treatments that harness a patient's immune system to fight cancer. Our conversation explores what it takes to turn a scientific discovery into a life-changing therapy and how AI is giving researchers new tools to understand complex data. Andrea also reflects on the mentors who shaped her career and explains why she believes the best leaders recognize potential in others before those individuals recognize it themselves. If you've ever wondered what happens between a breakthrough in the laboratory and a treatment in the hospital, you'll come away from this episode with a deeper appreciation for the people whose work is quietly reshaping the future of medicine.
Now licensed to see patients all across the country via telehealth: https://connectionDocs.com Free access to our emotional eating support AI coach - use link “https://connectionDocs.com/aicoach Our Substack - https://ConnectionDocs.substack.com Now licensed to see patients all across the country via telehealth: https://connectionDocs.com Free access to our emotional eating support AI coach - use link https://connectionDocs.com/aicoach Our Substack - https://ConnectionDocs.substack.com Transforming your health is more fun with friends! Join Chef AJ's Exclusive Plant-Based Community. Become part of the inner circle and start simplifying plant-based living - with easy recipes and expert health guidance. Find out more by visiting: https://community.chefaj.com/ ORDER MY NEW BOOK SWEET INDULGENCE!!! https://www.amazon.com/Chef-AJs-Sweet-Indulgence-Guilt-Free/dp/1570674248 or https://www.barnesandnoble.com/w/book/1144514092?ean=9781570674242 GET MY FREE INSTANT POT COOKBOOK: https://www.chefaj.com/instant-pot-download MY BEST SELLING WEIGHT LOSS BOOK: https://www.amazon.com/dp/1570674086?tag=onamzchefajsh-20&linkCode=ssc&creativeASIN=1570674086&asc_item-id=amzn1.ideas.1GNPDCAG4A86S Disclaimer: This podcast does not provide medical advice. The content of this podcast is provided for informational or educational purposes only. It is not intended to be a substitute for informed medical advice or care. You should not use this information to diagnose or treat any health issue without consulting your doctor. Always seek medical advice before making any lifestyle changes.
An honest and empowering conversation addressing common symptoms, emotional changes, and practical strategies to help survivors navigate this next phase with confidence and support.
This week, Bobbi Conner talks with MUSC Dr. William Hawkins about recent advances in pancreatic cancer treatment.
In this episode, I'm joined by Eddie Enever, a naturopath from Perth, Australia, and a stage 4 cancer survivor, who explains how he approaches integrative cancer care alongside conventional treatment. Eddie shares what he wishes more patients understood about hyperbaric oxygen therapy, treatment timing, recovery, and the risks of combining too many therapies without a clear strategy. You'll discover:• How hyperbaric oxygen therapy may fit alongside chemotherapy and other cancer treatments• Why more supplements and therapies are not always better• The foundations of cancer recovery, including nutrition, sleep, stress, and nervous system support• How Eddie approaches HBOT pressure, timing, and treatment blocks• What patients should consider after remission• Why rebuilding the body can be as important as targeting the tumor
https://holplus.co/appointments Are we over-treating breast cancer? Learn why metabolic dysfunction may be the real driver behind many diagnoses and how to rethink treatment.Approximately 20 to 30 percent of screen detected breast cancer cases are treated unnecessarily. This video challenges the current standard of breast cancer treatment by focusing on the underlying metabolic health factors that often go unaddressed. If you are concerned about the current approach to screening or are looking for a more preventative perspective, this discussion provides a critical look at how we diagnose and manage the disease.We break down the three major drivers that contribute to long-standing metabolic dysfunction. By identifying these root causes, we can move toward a more accurate breast cancer diagnosis and more effective, targeted strategies for long-term health.Subscribe for weekly health and metabolic disease breakdowns, and comment below with your thoughts on these new findings.If you are navigating cancer treatment or recovery, concerned about inflammation, or want personalized support for your hormones and nutrition, explore related Hol+ care options here:Cancer Support:https://holplus.co/services/cancer-support/Inflammation:https://holplus.co/conditions/inflammation/Hormone Balancing:https://holplus.co/services/hormone-balancing/0:00 Rethinking Breast Cancer Care1:04 Meet Dr. Jen Simmons2:59 A Family History of Cancer6:53 When the Doctor Becomes the Patient12:53 Why We Focus on the Wrong Thing18:51 Navigating a Diagnosis23:24 The Flaws in Mammographic Screening35:17 A New Paradigm for Breast Health*About Dr. Jenn Simmons:*Dr. Jenn Simmons is an Integrative Oncologist, Breast Surgeon, Author, Podcast Host, and the founder of PerfeQTion Imaging. Her journey into breast cancer care began with a personal tragedy. At the age of 16, Dr. Jenn's cousin, acclaimed singer-songwriter Linda Creed, died of metastatic breast cancer just weeks after Whitney Houston's recording of her iconic song, "The Greatest Love of All," topped the charts. This loss became a defining moment, inspiring Dr. Jenn to dedicate her life to transforming how we approach breast cancer treatment and prevention.Dr. Jenn became Philadelphia's first fellowship-trained breast surgeon and spent 17 years leading the field. However, her perspective changed significantly when she became a patient herself. Through this personal experience, Dr. Jenn saw how broken the conventional medical system can be. This led her to discover and embrace functional medicine, a revelation that sparked her journey towards a more holistic approach to breast cancer care.Connect with Dr. Jenn Simmons:https://www.realhealthmd.com/https://www.instagram.com/drjennsimmons/https://www.youtube.com/@dr.jennsimmonsAbout Dr. Taz:Dr. Tasneem Bhatia (Dr. Taz) is a triple board-certified integrative medicine physician,bestselling author, and founder of hol+ a multi-location integrative medicine practice.Learn more: https://doctortaz.com/aboutStay Connected:Connect further to Hol+ at https://holplus.co/ - Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+.Book a Hol+ Consultation: https://holplus.co/locations/virtual/Follow Dr. Taz on Instagram:https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Subscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsProduced by https://ClipGrowth.com (Producer: Pat Gostek)
Denise Salem, Oncology Chaplain at Riverside Healthcare, explains how pastoral care adds an extra layer of support alongside medical treatment by providing a listening presence, spiritual resources when wanted, and practical help for families and staff. She describes outpatient chaplain visits at the Riverside Cancer Institute and infusion clinics in Bourbonnais, Watseka, Frankfort, and Coal City; the non‑proselytizing, faith‑inclusive nature of chaplaincy; and common issues addressed—including fear of the unknown, guilt, loneliness, and the modern problem of “cancer ghosting.” Salem shares examples of how caregivers and friends can show up—daily texts, group devotions, or small creative gestures—how chaplains help patients identify reasons to hope (trusted medical teams, future milestones), and why adaptability and meeting patients where they are are central to effective pastoral care.
The Real Truth About Health Free 17 Day Live Online Conference Podcast
Should you go natural or conventional? Dr. Pai explains how to combine treatments based on labs, cancer type, and risk—plus avoid unnecessary therapies. #IntegrativeOncology #CancerCare #SmartMedicine
Join host Myrna Young as she delves into cancer care and treatments with Dr. Rohit Gosain and Dr. Rahul Gisain, the Oncology Brothers, board-certified hematologists and medical oncologists from New York. This episode explores separating medical facts from media hype, understanding complex cancer research, and addressing treatment disparities. Learn about breakthrough treatments, the importance of personalized medicine, and how informed decisions can impact outcomes. Whether you're a patient, caregiver, or healthcare enthusiast, gain valuable insights into navigating the evolving landscape of cancer care.The Oncology Brothers share their professional journey and why they chose to specialize in oncology and hematology. They discuss how fast-evolving cancer treatments are being communicated and documented at medical conferences and highlight the significance of unbiased perspectives when selecting the best treatment options. Myrna and the doctors also emphasize the importance of understanding screening guidelines and genetic mutations for personalized cancer treatment, discussing various cancer advances like targeted therapies and immunotherapy. This episode serves as an enlightening resource for anyone affected by cancer, offering both hope and practical advice.Key Takeaways:The Oncology Brothers emphasize the explosion of cancer research and development, pointing out the annual approval of new treatments, which brings hope despite the challenges of keeping up with this data.Conferences serve as vital platforms for cancer education, yet the reality of financial and bias conflicts in the healthcare industry necessitates informed and independent patient advocacy.Treatment personalization through genetic profiling and understanding patient-specific mutations are pivotal in tackling cancers more effectively and improving patient outcomes.Listeners are encouraged to seek knowledge on the available cancer treatments, understand screening guidelines, and engage in shared decision-making with healthcare providers for optimal cancer care.Despite disparities in healthcare access due to geographical and financial constraints, efforts are ongoing to make cutting-edge cancer treatments more widely available.Timestamp Summary0:00 Welcome & Introduction2:09 Understanding Cancer Education5:20 Conversations Around Cancer Treatments10:14 The Role of Medical Conferences15:09 Recent Advancements in Cancer Treatment24:39 Patient Advocacy and Treatment Questions31:09 Disparities in Cancer Treatment Access42:31 Closing Remarks and ResourcesResources:OncBrothers WebsiteOncBrothers Podcast on YouTube | Spotify | Apple PodcastsSocial Media: @ONCBrothers on X/TwitterSponsors for this Episode SquareSquare brings payments, POS, inventory, staffing, and online sales together in one system – so business owners don't have to juggle a bunch of tools. Right now, listeners can get up to $200 off Square hardware when you sign up at square.com/go/transformQuinceQuince is not just apparel. Quince also offers elevated essentials for your home, from bedding and bath, to kitchen essentials and furniture.Make your summer wardrobe feel easier. Go to Quince.com/tym for free shipping on your order and 365-day returns Link to Transcript https://www.buzzsprout.com/1761155/19533950-oncology-advances-inside-the-latest-breakthroughs-in-cancer-treatment/transcriptSee this video on The Transform Your Mind YouTube Channel https://www.youtube.com/@MyhelpsUs/videosTo see a transcripts of this audio as well as links to all the advertisers on the show page https://myhelps.us/Follow Transform Your Mind on Instagram https://www.instagram.com/myrnamyoung/Follow Transform Your mind on Facebookhttps://www.facebook.com/profile.php?id=100063738390977Please leave a rating and review on iTunes https://podcasts.apple.com/us/podcast/transform-your-mind/id1144973094Feedspot Top 100 Mental Health Podcast For sponsored Brand interviews and sponsorship inquires please visit Partner With The Transform Your Mind Podcast | Myrna Young Life Coach
On this episode host Justin Barnes continues his 7-part series at the Moffitt Cancer Center exploring oncology of today. Part 2, Cancer Treatment & Innovation Best Practices with Kamal Jethwani, MD, VP Digital Ventures & CEO AccelerOnc and Nainesh Parikh, MD, VP Chief Expansion & Partner Officer of the Center. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen
Dr. William Li is a Harvard-trained physician, co-founder of the Angiogenesis Foundation, and New York Times bestselling author whose work centers on one quietly radical premise: the power to stay healthy lives inside you. In this conversation, we explore the five hardwired defense systems the body runs continuously, angiogenesis, stem cells, the gut microbiome, immunity, and DNA protection, and what it looks like to actually support them through food, sleep, and daily choices.What We Dive Into:1. You are not just one organism. You carry 39 trillion bacteria inside you, many of which send signals up through the vagus nerve directly to the brain, shaping mood, social behavior, and stress levels.2. Your body was born with 70 million extra stem cells stored in bone marrow, ready to mobilize and repair damage whenever called. Sleep, food, and metabolic health directly influence how effectively they do their job.3. The environment is full of things we cannot fully control, microplastics, toxins, pollution. What we can control is whether our internal defense systems are strong enough to handle the load. Chronic stress degrades those systems faster than most environmental exposures.Know Thyself, but not by yourself. A guided space to return home to yourself.https://www.knowthyselfcollective.com✨THANK YOU TO OUR SPONSORS:https://drinkLMNT.com/KnowThyselfTry LMNT & get a free sample pack https://oneskin.co/KNOWTHYSELFCode KNOWTHYSELF for 15% off___________00:00 Intro01:42 Health Is Not the Absence of Disease05:24 The Five Health Defense Systems07:14 Defense 1: Angiogenesis and Blood Vessel Health09:07 Defense 2: Stem Cells and the Body's Repair System14:01 Defense 3: The Gut Microbiome and the Holobiont21:38 Defense 4: The Immune System as Inner Army31:44 Defense 5: DNA Repair and the Iron Dome Within36:48 Cancer Is Growing in All of Us Right Now43:07 The Rising Cancer Rates and Why They're Skewing Younger47:40 Microplastics: Where They Come From and Why They Matter55:37 The Case for Keeping Your Shields Up59:15 Practical Steps: Air, Water, and Food Quality1:07:46 Sleep, Movement, and Stress as Health Defenses1:11:04 The Danger of Chronic Overeating1:19:09 The History of Abundance and the Clean Plate Myth1:23:43 Bruce Lee and the Philosophy of Personalized Health1:29:00 What Modern Medicine Got Right and What It Lost1:32:42 The Interstitium, Acupuncture, and Converging Worlds1:35:34 The Future of Cancer Treatment and Health Span1:44:42 Dr. Li's Favorite Foods and Why He Loves Them1:55:53 The Science of Dark Chocolate1:59:00 Closing Message: Optimize Your Gut___________✨MORE FROM DR. WILLIAM LI↳Instagram: https://www.instagram.com/drwilliamli/↳Facebook: https://www.facebook.com/drwilliamli/↳YouTube: https://www.youtube.com/c/DrWilliamLi↳Eat to Beat Your Diet Book: https://drwilliamli.com/etb-diet-book/↳Eat to Beat Disease Book: https://drwilliamli.com/book-li/↳https://drwilliamli.com
In this episode of the Veterinary Cancer Pioneers Podcast, host Dr. Rachel Venable welcomes Dr. Michael Nolan, the Randall B. Terry Jr. Distinguished Professor of Oncology at North Carolina State University and a board-certified veterinary radiation oncologist. Dr. Nolan discusses how advances in radiation technology have transformed cancer treatment, from precisely targeting challenging tumors to exploring how radiation can enhance immunotherapy. The conversation also dives into his pioneering research on the connection between pain, the nervous system, and cancer biology, and how these discoveries could improve both patient comfort and cancer outcomes. Finally, Dr. Nolan shares promising early work combining radiation with novel targeted therapies for feline oral squamous cell carcinoma and offers insight into why pursuing overlooked research questions often leads to the biggest breakthroughs.
This conversation was originally recorded and published in November, 2024. In light of Richard's passing, we wanted to share it again because his insights remain as inspiring and relevant as ever. We extend our deepest condolences to his family, friends and colleagues.
Most people undergoing cancer treatments know to watch out for fatigue or hair loss, but far fewer expect the severe impact of oral mucositis. While it often begins as a painful side effect of chemotherapy or radiation, severe cases can rapidly cross the line into a critical oncology emergency.Learn why Stage 4 mucositis becomes a medical emergency and about life-threatening complications like sepsis, severe dehydration, and treatment interruptions. Then, we share a rebroadcast of our comprehensive guide with daily steps patients can take to protect their mouths, manage symptoms early, and preserve their quality of life.https://bit.ly/3Tqfl18 for helpful visuals, resources, and a mouth rinse recipeTimestamps:00:00 - Mucositis - What it is and Why it Can Become a Cancer Emergency07:34 - Intro S6E22 Mucositis with Cancer Treatment and How You can Prevent It09:18 - The Sharks of Rockaway Beach13:50 - Road Trip to Nebraska - Famous Murder Spree and Reuben Sandwich17:59 - Oral Mucositis - Common Symptom of Cancer Treatment21:24 - Why it is Important to be Proactive to Prevent Mucositis29:05 - Mucositis Discussion34:18 - Nutrition Tips for dehydration, taste changes and decreased appetite or pain while eating36:18 - Holly Butcher: Advice to World 24 Hours before She Died of Cancer38:16 - Outro with words from Killian Murphy#OncologyEmergency #OralMucositis #CancerCaregiver #ChemotherapySideEffects #CancerSupport #PatientEducation #SupportiveOncology #SepsisAwareness #MouthSoresSupport the show
Can focal therapy truly “thread the needle” between active surveillance and radical prostate cancer treatment? In this episode of BackTable Urology, host Dr. Tiwa Akinsola is joined by Dr. George Schade from the University of Washington to explore focal therapy as a middle ground between active surveillance and radical treatments. Dr. Schade reviews non-radiation energy modalities including HIFU, TULSA/HI-DU, cryotherapy, and irreversible electroporation, highlighting patient selection, institutional experience, technical nuances, and quality-of-life outcomes from recent trials. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps00:00 - Introduction02:09 - Overview of Focal Therapy Modalities04:46 - Deciding Between HIFU and IRE06:56 - Evidence and Trials09:40 - Counseling Patients on Outcomes12:09 - Building a Focal Therapy Program16:12 - Navigating Insurance and Appeals21:48 - Managing Large Glands And TURP25:12 - Preop Workup Essentials and OR Workflow32:32 - Overcoming the Learning Curve35:52 - PostOp Recovery and Surveillance39:04 - Options for Managing Recurrence42:44 - Challenges with Repeat Ablation44:56 - Final Takeaways --- More about this episodeThe conversation covers candidate selection and confirmatory biopsy, perioperative technique and recovery, and ongoing surveillance with PSA, MRI, and biopsy. Dr. Schade also discusses challenges with insurance approvals, building a focal therapy practice, and options for managing recurrence, including repeat ablation, surgery, or radiation. The episode examines how to balance cancer control with quality of life and reviews the evolving evidence base supporting focal therapy's role in prostate cancer treatment. --- Resources Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial:https://www.sciencedirect.com/science/article/pii/S030228382500346X Focal therapy of localized prostate cancerhttps://pubmed.ncbi.nlm.nih.gov/35996758/ Focal Therapy for Prostate Cancer: Available Technologies, Patient Selection, Follow-Up Protocols and Reported Outcomeshttps://pubmed.ncbi.nlm.nih.gov/41339218/ --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.► https://www.backtable.com/app
When we talk about EMF and cancer, the conversation usually focuses on risk. But what if electromagnetic fields could actually help treat cancer? In this episode, I break down a fascinating new study showing how pulsed electromagnetic field therapy altered the genetic profile of bladder cancer cells in the lab -- and what this tells us about the complex relationship between EMF and human biology. This isn't about fear. It's about understanding how the same technology that requires caution in one context might offer therapeutic benefits in another. In This Episode How pulsed electromagnetic fields changed gene expression in bladder cancer cells Why the same technology that poses risks can also treat disease What FDA-approved cancer treatments already use electromagnetic fields The key difference between therapeutic EMF and everyday exposure Featured Study Read the full study: Pulsed Electromagnetic Field Therapy Alters the Genomic Profile of Bladder Cancer Cell Line HT-1197 See all studies at shieldyourbody.com/research
This interview is disseminated on behalf of Medicus Pharma Ltd.With Phase 2 studies moving forward across its clinical programs, Medicus Pharma (NASDAQ: MDCX) is also planning to evaluate the use of its SkinJect anti-skin cancer patch to combat Gorlin Syndrome, a rare genetic disorder, as well as Teverelix for the potential treatment of endometriosis.Executive Chairman and CEO Dr. Raza Bokhari shares more details about the company's FDA application to test SkinJect in Gorlin Syndrome patients, its genomics-enabled clinical trial in Abu Dhabi for Teverelix's use in endometriosis, and anticipated growth milestones, including potential strategic partnerships.Learn more about Medicus Pharma: https://medicuspharma.com/Watch the full YouTube interview here: https://youtu.be/v_ZhrQE2DFMAnd follow us to stay updated: https://www.youtube.com/GlobalOneMedia
Thank you for joining us for our 2nd Cabral HouseCall of the weekend! I'm looking forward to sharing with you some of our community's questions that have come in over the past few weeks… Amy: Hi Dr Cabral. Many thanks for all that you do for this community! I'd love your advice on anal fissures. I had one recently that had begun healing. My doctor gave me Diltiazem/Lidocaine cream that I used 2x day and my fissure closed and developed healing/scar tissue. However, less than 2 months later, it's opened again. His suggestions previously involved either Botox injections or surgery if the cream had not worked and I would prefer to try and address it more naturally. Do you have any suggestions about what I can do to get this fissure to heal and stay healed naturally? I'm working on diet/fiber but that doesn't seem to be enough. One bad bout of constipation and it seems to undo anything I've done to help. Thanks! Anonymous: Hi Dr. Cabral. This is a bit of an intimate question. I'm having some sort of reaction after I have sexual intercourse. I get a prickly, itchy, warm sensation in my vagina, on my legs and stomach. Sometimes red bumps appear on my skin. Almost like I'm having an allergic reaction. Symptoms continue on and off for about 3 or 4 days then everything calms down and goes back to normal. It seems to happen more around ovulation and menstruation but recently happening anytime of the month. Any idea what is happening to me and what I can do to heal it?! To note, I'm 40 years old, still getting regular periods. Thank you for your help! Mke: Hi Dr Cabral, would love your thoughts. I have known for a year I've had silicosis & PMF (progressive massive fibrosis) I was misdiagnosed for the last 15 years they've told me I've had sarcoidosis. My wife is an IHP, and we have been doing foundational protocols/DNS/detoxes/heavy metal detox/saunas/coffee enemas etc for the past 3 years. I have a very physical job and do keep my cardio fitness up, which seems to help my breathing. We have just invested in a home soft shell hyperbaric chamber after speaking to a guy in the US who's lung function has dramatically improved (he has silicosis but not PMF) as well as investing in a rife machine. Do you have any advice, thoughts or info on slowing down or reversing scarring or anything that might help? Jamie: My daughter, nearly seven, has developed severe hay fever this year in the UK. She is constantly sneezing, has dark circles under her eyes, looks exhausted for almost three months, and her sleep, breathing, concentration and focus seem affected. She may also have a mild dairy intolerance, possibly linked to eczema in her inner elbows, though otherwise she is active and well. We also suspect slightly restricted sinus passages and mouth-breathing, and are considering seeing a functional-medicine-style dentist to support facial/skull development. Could you advise on practical ways to help her and whether any allergy or other tests would be worthwhile at her age to identify the root cause? Any initial guidance hugely welcome. Massive thank you to you your family and your team. Sarah: Last year I was diagnosed with stage 4 grade 3 endometrial cancer. I underwent six rounds of chemotherapy: Paclitaxel and carboplatin along with immunotherapy; jemperli. I also had a complete hysterectomy after the third round. Prior to treatment I had regular bowel movements. Now they are loose and very dark brown. I have very limited resources currently. What do you suggest I do to heal my gut? Thank you for tuning into this weekend's Cabral HouseCalls and be sure to check back tomorrow for our Mindset & Motivation Monday show to get your week started off right! - - - Show Notes and Resources: StephenCabral.com/3796 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!
What do you do when Y-90 doesn't deliver the results you expected? In this episode of the 2026 HCC Creator Weekend™, host Dr. Tyler Sandow is joined by Drs. Beau Toskich and Juan Gimenez to discuss the technical challenges and troubleshooting strategies that can make or break a Y-90 radioembolization case. Together, they explore innovative approaches like the PREDATr technique, share tips for reducing complications, and offer guidance on optimizing outcomes for patients with complex liver tumors. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Sirtex and Boston Scientific. --- Timestamps 00:00 - Introduction04:24 - Treatment Nonresponse Troubleshooting06:12 - Navigating Y90 Through Replaced Arteries09:09 - Mitigating Vasospasm in Embolization13:31 - What is ‘PREDATr'?21:12 - Dual Balloon Microcatheter System23:37 - Gelfoam Techniques and Application26:06 - Embolization Agents Preferences36:16 - Concerns with Cystic Artery Treatment and Biliary Stents42:15 - Prophylactic Antibiotics 44:29 - Utilizing High Lung Shunts49:28 - Wrap Up and Credits --- More about this episode The conversation begins with case-based examples of HCC radioembolization, focusing on how to assess treatment response and troubleshoot nonresponsive cases. They discuss how to interpret SPECT findings, identify missed tumor supply with cone-beam CT, and overcome obstacles such as vasospasm, extrahepatic feeders, and challenging arterial anatomy. They introduce the PREDATr technique (proximal radioembolization enabled by distal angiozone truncation) and explain how tools like gelfoam, balloons, and retrievable coils can preserve healthy liver tissue and improve microsphere delivery. The episode also addresses managing biliary stents, using antibiotic prophylaxis, and strategies for handling high lung shunts, making it a practical resource for anyone navigating the complexities of Y-90 treatment. --- BackTable Vascular & Interventional (VI) is the go-to podcast for interventional radiologists, vascular surgeons, and interventional cardiologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
© 2020-2026 Ivy Podcast Discovery LLC
